Correlation between CHA2DS2-VASc Score and Glaucoma Treatment and Prognosis by Yoav Y. Pikkel, Daniel Krebs, Vadim Igal, Adi Sharabi-Nov, Irena Epstein, Joseph Pikkel

“…Purpose. To find if CHA2DS2-VASc scale can accurately predict the treatment, prognosis, and outcome for primary open-angle glaucoma (POAG). …”
Get full text

CHA2DS2-VASc Score Is Associated With Prognosis in Patients With Acute Ischemic Stroke Without Atrial Fibrillation by Mingjuan Song, MM, Xu Chen, MD

“…Patients were categorized into high-risk (CHA2DS2-VASc score, >2; n = 424), moderate-risk (CHA2DS2-VASc score, 2; n = 218), and low-risk (CHA2DS2-VASc score, 0-1; n = 351) groups. …”
Get full text

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA2DS2-VASc Score in Anticoagulated Patients with Atrial Fibrillation by Roberto Carnevale, Daniele Pastori, Mariangela Peruzzi, Elena De Falco, Isotta Chimenti, Giuseppe Biondi-Zoccai, Ernesto Greco, Antonino G. M. Marullo, Cristina Nocella, Francesco Violi, Pasquale Pignatelli, Camilla Calvieri, Giacomo Frati

“…A multivariable linear regression analysis showed that CHA2DS2-VASc score (B −0.227, P<0.001) and sCD40L (B −0.524, P<0.001) correlated to APN. …”
Get full text

Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction by Caoyang Fang, Zhenfei Chen, Jing Zhang, Xiaoqin Jin, Mengsi Yang

“…This study investigates the predictive value of the admission CHA2DS2-VASc score for in-hospital MACE in STEMI patients. …”
Get full text

Role of the CHADS-VASc score in predicting hospital stay and 90-day readmission among patients with atrial fibrillation in Syria by Ibrahim Antoun, Alamer Alkhayer, Alkassem Alkhayer, Yaman Mahfoud, Ahmed Kotb, Riyaz Somani, G André Ng, Mustafa Zakkar

“…Objectives We assessed the CHA 2 DS 2 -VASc score for predicting hospital readmission risk and length of stay (LOS) in patients admitted with primary atrial fibrillation (AF). …”
Get full text

Novel Models for the Prediction of Left Atrial Appendage Thrombus in Patients with Chronic Nonvalvular Atrial Fibrillation by Do Van Chien, Pham Thai Giang, Pham Truong Son, Le Van Truong, Pham Nguyen Son

“…These models combine the CHA2DS2-VASc score with LA volume index and LA longitudinal strain parameters measured on speckle tracking echocardiography in the four-chamber view. …”
Get full text

Coronary Embolism despite CHA₂DS₂-VASc Score of Zero: Should We Reconsider Anticoagulation? by Ammar Ahmed, Andrew Assaf, Aditi Shankar, Marcel Zughaib

“…A presumptive diagnosis of coronary embolism secondary to paroxysmal atrial fibrillation was made, and the patient was started on anticoagulation despite a low CHA2DS2-VASc score. This case not only highlights coronary embolism but also illustrates that a low CHA2DS2-VASc score does not mean there is no risk of emboli. …”
Get full text

Predictive value of peripheral blood SNORD55 for prognosis of atrial fibrillation patients by WANG Yu, WANG Yu, WU Na, YANG Lanqing

“…The predictive performance of CHA2DS2-VASc score for all-cause mortality and stroke was compared with the score combined with the relative expression level of SNORD55 in the AF patients. …”
Get full text

Association between triglyceride glucose index and adverse cardiovascular prognosis in patients with atrial fibrillation without diabetes: a retrospective cohort study by Aobo Gong, Ying Cao, Zexi Li, Wentao Li, Fanghui Li, Yao Tong, Xianjin Hu, Rui Zeng

“…The predictive performance of the CHA2DS2-VASc model was evaluated after incorporating the Tyg index. …”
Get full text

Development and Validation of a Nomogram for Predicting Mortality in Patients with Atrial Fibrillation and Acute Coronary Syndrome Who Underwent Percutaneous Coronary Intervention... by Can Hua, Haitao Tian, Yubin Wang, Jianyong Zheng, Pengfei Liu, Boyang Zhang, Nannan Wang, Haihong Tang, Feng Wang, Xiufeng Xie, Haifeng Yuan, Tianchang Li

“…In the validation cohort, the C-index of the nomogram for predicting all-cause death was 0.706 (95% CI 0.601-0.811), with no significant differences compared with GRACE and CRUSADE, but better than that of CHA2DS2-VASc and HAS-BLED. Conclusions. The nomogram has good prognostic prediction for patients with AF and ACS who underwent PCI.…”
Get full text

Female Sex as a Thromboembolic Risk Factor in the Era of Nonvitamin K Antagonist Oral Anticoagulants by Mariacarla Gallù, Giulia Marrone, Jacopo Maria Legramante, Antonino De Lorenzo, Nicola Di Daniele, Annalisa Noce

“…The introduction of novel oral anticoagulants (NOACs) for long-term anticoagulation completely changed the anticoagulant therapeutic approach and follow-up of patients affected by nonvalvular atrial fibrillation (NVAF). CHA2DS2-VASc stroke risk scoring in use in the current international guidelines attributes 1 point to “female sex”. …”
Get full text

One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study by Ayman Hammoudeh, Yousef Khader, Ramzi Tabbalat, Yahya Badaineh, Nazih Kadri, Haneen Shawer, Eyas Al-Mousa, Rasheed Ibdah, Batool A. Shawer, Imad A. Alhaddad

“…The strongest independent predictors for stroke/SE were high-risk CHA2DS2-VASc score and prior history of stroke. Conclusions. …”
Get full text

Combined Catheter Ablation and Left Atrial Appendage Closure in Atrial Fibrillation Patients with and without Prior Stroke by Bin-Feng Mo, Rui Zhang, Jia-Li Yuan, Jian Sun, Peng-Pai Zhang, Wei Li, Mu Chen, Qun-Shan Wang, Yi-Gang Li

“…Patients in the Stroke group had higher CHA2DS2-VASc scores (4.9 ± 1.2 vs. 3.2 ± 1.0, P<0.001) and higher HAS-BLED scores (3.5 ± 1.1 vs. 3.0 ± 1.0, P<0.001) compared with those in the Control group. …”
Get full text

Recurrence of atrial fibrillation and late cardiovascular events in patients with persistent atrial fibrillation after restoration of sinus rhythm by U.P. Chernyaha-Royko, N.S. Pavlyk, M.S. Sorokivskyy, A.V. Aker, O.J. Zharinov

“…Patients with events had a higher risk of CHA2DS2-VASc (p = 0.05), lower LV EF (p = 0.00009), more symptomatic recurrence of AF (p = 0.08), ventricular arrhythmias (p = 0.08) and short-run atrial tachyarrhythmia lasting up to 30 seconds (p = 0.05) according to EM; AF more often turned into permanent form (p = 0.002). …”
Get full text

Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analys... by Gregory Y H Lip, Sally Lee, Brigitta U Monz, Andreas Clemens, Martina Brueckmann

“…The results were then stratified by risk of stroke using CHADS2 and CHA2DS2-VASc.Results 83 898 patients with AF were identified in the GPRD. …”
Get full text

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic eve... by Raffaele De Caterina, Kurt Huber, Richard Schilling, Miklos Rohla, Thomas W Weiss, Ladislav Pecen, Giuseppe Patti, Jolanta M Siller-Matula, Renate B Schnabel, Dipak Kotecha, Markus Lucerna, Paulus Kirchhof

“…Objectives We identified factors associated with thromboembolic and bleeding events in two contemporary cohorts of anticoagulated patients with atrial fibrillation (AF), treated with either vitamin K antagonists (VKA) or non-VKA oral anticoagulants (NOACs).Design Prospective, multicentre observational study.Setting 461 centres in seven European countries.Participants 5310 patients receiving a VKA (PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF), derivation cohort) and 3156 patients receiving a NOAC (PREFER in AF Prolongation, validation cohort) for stroke prevention in AF.Outcome measures Risk factors for thromboembolic events (ischaemic stroke, systemic embolism) and major bleeding (gastrointestinal bleeding, intracerebral haemorrhage and other life-threatening bleeding).Results The mean age of patients enrolled in the PREFER in AF registry was 72±10 years, 40% were female and the mean CHA2DS2-VASc Score was 3.5±1.7. The incidence of thromboembolic and major bleeding events was 2.34% (95% CI 1.93% to 2.74%) and 2.84% (95% CI 2.41% to 3.33%) after 1-year of follow-up, respectively.Abnormal liver function, prior stroke or transient ischaemic attack, labile international normalised ratio (INR), concomitant therapy with antiplatelet or non-steroidal anti-inflammatory drugs, heart failure and older age (≥75 years) were independently associated with both thromboembolic and major bleeding events.With the exception of unstable INR values, these risk factors were validated in patients treated with NOACs (PREFER in AF Prolongation Study, 72±9 years, 40% female, CHA2DS2-VASc 3.3±1.6). …”
Get full text

Mitral Stenosis Berat pada Penyakit Jantung Rematik by Cokorda Istri Padmi Suwari, Widyawati Desak Gede

“…The patient was diagnosed with CHF FC II ec RHD + MS moderate-severe (Wilkins score 8) + AF NVR (CHA2DS2VASc 3) and treated with heart failure and antiplatelet medication. …”
Get full text

Predictors of the occurrence of cardiovascular events in patients with atrial flutter during long-term follow-up by A.V. Aker, U.P. Chernyaga-Royko, N.S. Pavlyk, O.J. Zharinov

“…Patients with events have had MI earlier (11 (12.9 %) vs 16 (39.0 %), p = 0.002), they had a slightly higher risk of thromboembolic events over CHA2DS2-VASc score (p = 0.062). In the second group hemodynamic disorders were more frequently observed in the index episode (17.1 % vs. 3.5 %, p = 0.03) and sinus rhythm was less frequently recorded at the time of discharge from hospital 20 (48.7 %) vs 58 (68.2 %), p = 0.049) compared to patients without complications. …”
Get full text

The Value of Voltage Histogram Analysis Derived Right Atrial Scar Burden in the Prediction of Left Atrial Scar Burden by Szilvia Herczeg, Joseph Galvin, John J. Keaney, Edward Keelan, Roger Byrne, Claire Howard, Laszlo Geller, Gabor Szeplaki

“…The percentage of RA diseased tissue burden was significantly higher in patients with a CHA2DS2-VASc score ≥ 2 p=0.0305, higher indexed LA volume on the CTA scan and on the HD‐EAM (p=0.0223 and p=0.0064, respectively), or higher indexed RA volume on the HD‐EAM p=0.0026. …”
Get full text

Integration of a specialist pharmacist-led multidisciplinary team in primary care: preventing strokes in people with atrial fibrillation across North East London by Riyaz Patel, Sotiris Antoniou, Shabana Ali, Mital Patel, Matt Kearney, Jagjot Kaur Chahal, John Robson, Paul Wright, Afzal Sohaib, Richard Clements, Angela Theodoulou

“…Evidence shows that one stroke can be prevented for every 25 patients with AF treated with anticoagulation, reducing the burden of stroke and stroke-related disabilities.In 2020, hospital specialist cardiovascular pharmacists were commissioned to identify patients with AF at high ischaemic risk (CHA2DS2VASc≥2) in three boroughs by working with general practitioners (GPs) and practice-based pharmacists. …”
Get full text